PARIS — Danone has acquired Functional Formularies, a whole food, shelf-stable, organic feeding tube formula company, from Swander Pace Capital. Terms of the acquisition were not disclosed.

Functional Formularies, which was acquired by Swander Pace in November 2018, will join Danone’s medical nutrition portfolio in the United States.

“I am so proud of our team’s ability to deliver high-quality ingredients to help with improved patient outcomes,” said Marc Gibeley, chief executive officer of Functional Formularies. “This has been an extremely rewarding journey, and partnering with the SPC team has been a pleasure. Their strategic perspective, network and broader category insights were key enablers of the team’s success and are greatly appreciated.”

Functional Formularies was founded in 2006 by chef and nutrition expert Robin Gentry McGee. She created the company to offer natural alternatives to traditional feeding tube formulas when her father suffered severe health issues.

Functional Formularies plant-based product line features an adult formula Liquid Hope, a pediatric formula Nourish and a ketogenic formula Keto.

“It was a pleasure to work with the Functional Formularies team; their hard work and dedication enabled a fantastic result,” said Mo Stout, managing director at SPC. “This is a great example of SPC’s ability to partner with management teams to help accelerate growth and build value. We wish the Functional Formularies team all the success going forward and are confident they will continue to deliver results for patients and families for many years to come.”